Filter
3029
Filtered Results: 3029
Text search:
tb
preve
Featured
Recommendations
270
New Publications
859
Language
Document type
No document type
1925
Guidelines
373
Studies & Reports
343
Manuals
135
Strategic & Response Plan
118
Training Material
45
Fact sheets
42
Situation Updates
20
Infographics
14
Resource Platforms
7
Brochures
5
Online Courses
1
Videos
1
Countries / Regions
India
160
South Africa
115
Kenya
111
Global
81
Western and Central Europe
80
Tanzania
70
Ethiopia
66
Uganda
63
Zambia
63
Sierra Leone
54
Nepal
51
Malawi
51
Nigeria
49
Liberia
48
Namibia
47
Africa
47
Rwanda
46
Ghana
44
Eastern Europe
42
Latin America and the Carribbean
41
Peru
40
Myanmar / Burma
38
Colombia
34
Bangladesh
33
Lesotho
29
Mozambique
28
Paraguay
28
Ukraine
26
Cambodia
25
Asia
25
Zimbabwe
24
Philippines
24
South–East Asia Region
24
Argentina
23
Brazil
19
Venezuela
19
El Salvador
18
South Sudan
15
Botswana
15
Bolivia
14
Indonesia
12
East and Southern Africa
12
Senegal
11
Eswatini/ Swaziland
11
Congo, Democratic Republic of
9
Pakistan
9
Germany
9
Ecuador
9
Russia
9
Syria
8
Guinea
6
Benin
6
Chile
6
West and Central Africa
6
Albania
6
Tajikistan
6
Georgia
6
Haiti
5
Sudan
5
Southern Africa
5
Laos
5
Vietnam
5
Uruguay
5
Thailand
4
Papua New Guinea
4
Angola
4
Middle East and North Africa
4
Western Pacific Region
4
Armenia
4
Timor Leste/ East Timor
4
Jordan
3
Afghanistan
3
Burundi
3
Sri Lanka
3
Moldova
3
Burkina Faso
2
Guinea-Bissau
2
USA
2
Cameroon
2
Somalia
2
Iraq
2
Lebanon
2
Central African Republic
2
Honduras
2
Mexico
2
Nicaragua
2
Yemen
2
Eastern Europe and Central Asia
2
Bhutan
2
Poland
2
Romania
2
Iran
2
North America
2
Morocco
1
Saudi Arabia
1
Gambia
1
Ireland
1
Singapore
1
Dominican Republic
1
Switzerland
1
Hungary
1
Greece
1
Guatemala
1
Solomon Islands
1
North Korea
1
Gabon
1
Turkmenistan
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1416
Clinical Guidelines
216
Public Health
122
Women & Child Health
100
Key Resources
60
Capacity Building
50
Pharmacy & Technologies
26
Annual Report MEDBOX
2
Toolboxes
TB
629
HIV
408
COVID-19
141
AMR
112
Caregiver
61
Mental Health
56
Pharmacy
48
Global Health Education
42
NTDs
42
Ebola
41
NCDs
36
Disability
35
Conflict
34
Refugee
33
Rapid Response
31
Health Financing Toolbox
27
Planetary Health
22
Polio
19
Natural Hazards
15
Social Ethics
7
Cholera
5
Zika
5
Specific Hazards
5
South Sudan
1
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid...
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
La leishmaniasis es una enfermedad tropical desatendida sensible
al clima, trasmitida por la picadura de insectos flebótomos y
se calcula que amenaza a mil millones de personas en todo el mundo.
Esta enfermedad altamente compleja se presenta de varias formas
clínicas, causadas por 20 especies ...
Les pays progressent vers la réalisation de l’objectif mondial tendant à ce que, d’ici 2025, 95 pour cent des personnes qui vivent avec le VIH connaissent leur statut sérologique. Cependant, en 2020, on estimait encore à 6 millions le nombre de personnes séropositives non diagnostiquées da...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology including disease distribution and risk, the models
for estimating under-detection, the geographical variati...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
Since 24 February 2022, the war in Ukraine has caused widespread suffering to its people and serious damage
to the country’s infrastructure. Attacks on the country’s health system and its power network threaten people, compromise the provision of health care, and complicate the distribution of ...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
